Andrews Liver Salts Effervescent Powder

Land: Irland

Språk: engelska

Källa: HPRA (Health Products Regulatory Authority)

Aktiva substanser:

Sodium hydrogen carbonate; Citric acid anhydrous; Magnesium sulphate dihydrate

Tillgänglig från:

Haleon Ireland Limited

ATC-kod:

A06AD; A06AD04; A09AB; A09AB04

INN (International namn):

Sodium hydrogen carbonate; Citric acid anhydrous; Magnesium sulphate dihydrate

Dos:

22.6 17.4 19.5 %w/w

Läkemedelsform:

Effervescent powder

Receptbelagda typ:

Product not subject to medical prescription

Terapiområde:

Osmotically acting laxatives; magnesium sulfate; Acid preparations; citric acid

Bemyndigande status:

Marketed

Tillstånd datum:

1992-02-25

Bipacksedel

Page 3 of 10

Produktens egenskaper

Health Products Regulatory Authority
20 June 2023
CRN00DKSP
Page 1 of 3
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Andrews Liver Salts Effervescent Powder
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Effervescent powder containing magnesium sulphate (dihydrate) 17.4 %
w/w, sodium hydrogen carbonate 22.6 % w/w and
citric acid (anhydrous) 19.5 % w/w.
Excipient: Sucrose 40.5% w/w
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Effervescent powder.
A white free-flowing powder which effervesces on addition to water.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
The product is recommended as a laxative and as an antacid for the
treatment of dyspeptic symptoms.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
For oral use only.
_Adults (including the elderly):_ As an antacid, one to two level
spoonfuls (5-10 ml) in a glass of water. As a laxative, two level
spoonfuls (10 ml) in a glass of water to be taken before breakfast or
at bedtime.
_Children (aged over 6 years):_ Half the adult dose.
Not suitable for children under 6 years of age except under medical
advice.
4.3 CONTRAINDICATIONS
This product should not be given to patients with a hypersensitivity
to any component of Andrews Liver Salts or any previous
hypersensitivity to Andrews Liver Salts.
This product should not be given to patients with symptoms of
appendicitis, intestinal obstruction, inflammatory bowel disease,
or abdominal pain of unknown origin.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Because of the sodium content, frequent use by patients on a low
sodium diet should be avoided. This includes patients with
hypertension and cardiac or renal dysfunction. Magnesium salts may
cause central nervous depression in patients with renal
dysfunction.
Because of the sucrose content, diabetics should use with caution.
Patients with rare hereditary problems of fructose
intolerance, glucose-galactose malabsorption or sucrase – isomaltase
insufficiency should not take this medicine.
If a laxative is required every day, if t